Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
190.00
-4.50 (-2.31%)
Aug 22, 2025, 1:30 PM CST

TPE:6919 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
294,69394,36523,5407,528--
Upgrade
Market Cap Growth
141.73%300.87%212.69%---
Upgrade
Enterprise Value
285,30184,68522,6946,297--
Upgrade
Last Close Price
190.0061.5019.136.11--
Upgrade
PS Ratio
6573.282123.71604.64587.23--
Upgrade
PB Ratio
31.369.736.296.47--
Upgrade
P/TBV Ratio
31.369.736.296.47--
Upgrade
EV/Sales Ratio
-1905.86582.91491.18--
Upgrade
Debt / Equity Ratio
0.000.000.010.030.062.81
Upgrade
Asset Turnover
0.010.010.020.010.030.05
Upgrade
Inventory Turnover
2.137.045.992.252.412.89
Upgrade
Quick Ratio
117.48183.4250.4823.0415.001.45
Upgrade
Current Ratio
118.02184.0250.8123.4115.261.72
Upgrade
Return on Equity (ROE)
-9.69%-8.76%-19.92%-31.64%-64.89%-528.22%
Upgrade
Return on Assets (ROA)
-6.44%-6.59%-12.68%-20.53%-30.68%-33.22%
Upgrade
Return on Capital (ROIC)
-6.52%-6.65%-12.96%-21.32%-33.58%-40.80%
Upgrade
Earnings Yield
-0.21%-0.62%-2.08%-3.80%--
Upgrade
FCF Yield
-0.16%-0.56%-1.84%-3.41%--
Upgrade
Buyback Yield / Dilution
-13.79%-15.40%-5.77%-27.35%-23.49%-6.52%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.